Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;

Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing Fan Yang; Kaige Deng; Haoran Zheng; Zhenting Liu; Yongchang Zheng;